Journal
EXPERT OPINION ON DRUG SAFETY
Volume 21, Issue 8, Pages 1047-1060Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14740338.2022.2084071
Keywords
Harms; ADEs; older people; RACFs; drug-related harm; medication-related harm
Categories
Ask authors/readers for more resources
This narrative review investigates the types, prevalence, reporting, and identification methods of actual drug-related harms in older residents in residential aged care facilities.
Introduction Older people in residential aged care facilities (RACFs) have a high risk of safety issues and concerns about the potential quality of care received. This narrative review investigates the types of actual drug-related harms, their prevalence, reporting of any standard definitions for these harms, and their identification methods. Areas covered The authors conducted a systematic search on Ovid Embase, Ovid Medline, and PubMed from March 2001 to March 2021. This narrative review included all types of studies targeting aged care residents aged 65 years and above with actual drug-related harms. Expert opinion The prevalence of actual drug-related harms in residents ranged from 0.07% to 63.0%. Falls, drug-drug interactions, neuropsychiatric symptoms, anaphylaxis, urinary tract infection, hypoglycemia, hypokalaemia, and acute kidney injury are the most common drug-related harms in older residents. Psychotropic drugs are the most common drug class implicated in these harms. Evidence related to the association between individual psychotropic drugs and injury, or harm is also lacking. Due to the variation in study duration, reported prevalence, identification methods, and absence of a definition for actual drug-related harms in most studies, further research is mandated to understand the prevalence and clinical implications of drug-related harms in older residents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available